logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Harbour BioMed-B (02142.HK) repurchased 300,000 shares on October 20 for HK$3.1408 million.

date
20/10/2026
Zhitong Finance APP News, HBM Holdings-B (02142.HK) announced that on October 20, 2026, the company spent HK$3.1408 million to repurchase 300,000 shares at a repurchase price of HK$10.34-10.5 per share.
Latest
2 m ago
Zhongyu Energy (03633.HK) repurchased 400,000 shares for HK$1.0802 million on October 20.
3 m ago
Qinhuangdao Port (03369.HK) plans to acquire equity in four port companies; A-shares suspended
4 m ago
Changchun High-Tech (000661.SZ) subsidiary's GenSci155 injection clinical trial application accepted
5 m ago
RTX Corporation (RTX.US) reported total revenue of $24.965 billion for the third quarter of fiscal year 2026, up 11% year-over-year. Diluted earnings per share were $1.89 (prior period $1.41), up 34% year-over-year. Net income was $2.583 billion, up 35% year-over-year. Non-GAAP net income was $3.091 billion, up 34% year-over-year, and Non-GAAP earnings per share were $2.26 (prior period $1.7). Among the segments, Pratt & Whitney revenue was $9.231 billion, up 10% year-over-year; Collins Aerospace revenue was $8.382 billion, up 10% year-over-year; and Raytheon revenue was $8.031 billion, up 14% year-over-year. The company raised its full-year 2026 adjusted sales guidance to $97 billion to $97.5 billion, adjusted earnings per share guidance to $7.65 to $7.75, and free cash flow guidance to $9 billion to $9.2 billion; the organic sales growth rate guidance was raised to 10% to 11%. RTX Chairman and Chief Executive Officer Chris Calio said: "Our strong execution and operational focus in the third quarter enabled RTX to deliver double-digit organic sales growth across commercial aerospace and defense. Demand for our products remains strong, and we booked more than $81 billion in new commercial and defense orders in the quarter, bringing backlog to a record $340 billion." "Given our year-to-date performance, we are again raising our full-year outlook for adjusted sales, adjusted earnings per share and free cash flow. We will continue to focus on increasing production, optimizing our cost structure and investing in new technologies to support our customers and drive continued growth."
5 m ago
Sunshine Dairy: Abnormal Stock Trading Fluctuations, No Material Matters Requiring Disclosure That Have Not Been Disclosed
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.